Peritonitis in continuous ambulatory peritoneal dialysis patients in Southern Israel

  • J. Benjamin
  • , D. B.E. Gradus
  • , M. Mostoslavski
  • , J. Rapoport
  • , C. Chaimovitz

    Research output: Contribution to journalArticlepeer-review

    3 Scopus citations

    Abstract

    We report our experience of peritonitis in a group of continuous ambulatory peritoneal dialysis (CAPD) patients in the south of Israel during a 3-year period. During this period, 51 patients were treated with CAPD, comprising a total of 999 patient months of treatment. One hundred and forty-three episodes of peritonitis occurred in 42 patients. When the patients were divided into high risk and low risk groups, the overall incidence was one episode every 5.7 months in the high risk group and one episode every 13.2 months in the low risk group. Gram-positive organisms accounted for 62.2% of the infections, and coagulase negative Staphylococcus for 35% of infections. The recurrence rate was 12%. Catheter removal was required in seven patients, and three patients were transferred to hemodialysis because of recurrent infections. We conclude that CAPD is a safe and viable modality of treatment for end-stage renal disease in our patient population.

    Original languageEnglish
    Pages (from-to)699-702
    Number of pages4
    JournalIsrael Journal of Medical Sciences
    Volume25
    Issue number12
    StatePublished - 1 Dec 1989

    Keywords

    • continuous ambulatory peritoneal dialysis
    • end-stage renal disease
    • peritonitis

    ASJC Scopus subject areas

    • Bioengineering

    Fingerprint

    Dive into the research topics of 'Peritonitis in continuous ambulatory peritoneal dialysis patients in Southern Israel'. Together they form a unique fingerprint.

    Cite this